These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30721246)

  • 21. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.
    Mirzaei H; Gholamin S; Shahidsales S; Sahebkar A; Jaafari MR; Mirzaei HR; Hassanian SM; Avan A
    Eur J Cancer; 2016 Jan; 53():25-32. PubMed ID: 26693896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanoma prognosis: a REMARK-based systematic review and bioinformatic analysis of immunohistochemical and gene microarray studies.
    Schramm SJ; Mann GJ
    Mol Cancer Ther; 2011 Aug; 10(8):1520-8. PubMed ID: 21659462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of microRNA-106b and its clinical significance in cutaneous melanoma.
    Lin N; Zhou Y; Lian X; Tu Y
    Genet Mol Res; 2015 Dec; 14(4):16379-85. PubMed ID: 26662433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
    Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
    J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces.
    Riefolo M; Porcellini E; Dika E; Broseghini E; Ferracin M
    Mol Oncol; 2019 Jan; 13(1):74-98. PubMed ID: 30499222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic potential of alternative transcript isoforms across human tumors.
    Trincado JL; Sebestyén E; Pagés A; Eyras E
    Genome Med; 2016 Aug; 8(1):85. PubMed ID: 27535130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Functional Evaluation of miR-4633-5p as a Biomarker and Tumor Suppressor in Metastatic Melanoma.
    Zou B; Zhu W; Liu H; Wang S; Zhu H
    Cell Physiol Biochem; 2018; 49(4):1364-1379. PubMed ID: 30205394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melastatin expression and prognosis in cutaneous malignant melanoma.
    Duncan LM; Deeds J; Cronin FE; Donovan M; Sober AJ; Kauffman M; McCarthy JJ
    J Clin Oncol; 2001 Jan; 19(2):568-76. PubMed ID: 11208852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of diagnostic, prognostic, and predictive biomarkers in melanoma.
    Ankeny JS; Labadie B; Luke J; Hsueh E; Messina J; Zager JS
    Clin Exp Metastasis; 2018 Aug; 35(5-6):487-493. PubMed ID: 29722000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer.
    Durante G; Broseghini E; Comito F; Naddeo M; Milani M; Salamon I; Campione E; Dika E; Ferracin M
    Expert Rev Mol Diagn; 2022 Mar; 22(3):305-318. PubMed ID: 35235479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells.
    Komina A; Palkina N; Aksenenko M; Tsyrenzhapova S; Ruksha T
    PLoS One; 2016; 11(12):e0168229. PubMed ID: 28005927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
    Mueller DW; Bosserhoff AK
    Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating epigenetic biomarkers in melanoma.
    Xin Y; Li Z; Chan MT; Wu WK
    Tumour Biol; 2016 Feb; 37(2):1487-92. PubMed ID: 26662802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward predicting metastatic progression of melanoma based on gene expression data.
    Li Y; Krahn JM; Flake GP; Umbach DM; Li L
    Pigment Cell Melanoma Res; 2015 Jul; 28(4):453-63. PubMed ID: 25847062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.
    Wang K; Zhang ZW
    Int J Clin Exp Pathol; 2015; 8(10):13249-54. PubMed ID: 26722525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of galectin-3 expression with melanoma progression and prognosis.
    Brown ER; Doig T; Anderson N; Brenn T; Doherty V; Xu Y; Bartlett JM; Smyth JF; Melton DW
    Eur J Cancer; 2012 Apr; 48(6):865-74. PubMed ID: 22071132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low Expression of Mir-137 Predicts Poor Prognosis in Cutaneous Melanoma Patients.
    Li N
    Med Sci Monit; 2016 Jan; 22():140-4. PubMed ID: 26763596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
    Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X
    J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.